Stock represents the two fields coding and biology that determine the identity of every human cell.

Sign up today and learn more about Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Stock is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy. Collaboration is at the heart of We are empirical, highly ambitious and driven by a common purpose.

Funding History

March 2019$3.8M
February 2020$412K
February 2020$41.1M
September 2021$3.5M
September 2021$137M



Mark Kotter


Florian Schuster


splento - Jan, 20 2022

Top 25 BioTech startups

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: